FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 33 filers reported holding FUSION PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,680 | -48.1% | 700 | 0.0% | 0.00% | – |
| Q2 2023 | $3,234 | +23.2% | 700 | 0.0% | 0.00% | – |
| Q1 2023 | $2,625 | -12.7% | 700 | -20.0% | 0.00% | – |
| Q4 2022 | $3,006 | +5.4% | 875 | 0.0% | 0.00% | – |
| Q3 2022 | $2,853 | +22.3% | 875 | 0.0% | 0.00% | – |
| Q2 2022 | $2,333 | -67.4% | 875 | 0.0% | 0.00% | – |
| Q1 2022 | $7,162 | +58.5% | 875 | 0.0% | 0.00% | – |
| Q4 2021 | $4,520 | – | 875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 2,973,744 | $24,028,000 | 4.99% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12,613,000 | 4.97% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $29,658,000 | 3.03% |
| Sio Capital Management, LLC | 266,107 | $2,150,000 | 0.53% |
| Orbimed Advisors | 3,224,770 | $26,056,000 | 0.26% |
| Perceptive Advisors | 3,550,334 | $28,686,000 | 0.19% |
| AlphaCentric Advisors LLC | 71,500 | $578,000 | 0.16% |
| Rock Springs Capital Management LP | 948,327 | $7,662,000 | 0.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20,618,000 | 0.15% |
| Artal Group S.A. | 750,000 | $6,060,000 | 0.12% |